Unfortunately, there is a "Jekyll and Hyde" aspect to many pharma companies today as they struggle with the dictates of shareholders and the whole blockbuster model. Nowhere was that more evident
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
The drugmaker failed to pay the appropriate rebates to Medicaid and other goverment health care programs, and also paid kickbacks to doctors and hospitals to induce them to prescribe various meds. Th
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
Merck & Co., Inc. said that it has reached civil settlements with federal and state authorities to resolve longstanding investigations related to disputes over the proper calculation of Medicaid reba
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
A few day ago, Schering-Plough ceo Fred Hassan appeared on CNBC's Mad Money, where he spoke with Jim Cramer, the hyperactive host, about the controversy surrounding Vytorin. In particular, Cramer as
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
Merck & Co., Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended two medicines for marketing approval in the European Union
read more » Discuss Add this link to...Bury Add to:
| Bookmarks